ID: ALA566469

Max Phase: Preclinical

Molecular Formula: C22H22N2

Molecular Weight: 314.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#CCCCN(Cc1ccccc1)Cc1ccc2ccccc2c1

Standard InChI:  InChI=1S/C22H22N2/c23-14-6-7-15-24(17-19-8-2-1-3-9-19)18-20-12-13-21-10-4-5-11-22(21)16-20/h1-5,8-13,16H,6-7,15,17-18H2

Standard InChI Key:  LUOWOCACBZBWAD-UHFFFAOYSA-N

Associated Targets(non-human)

Neurokinin 2 receptor 373 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 314.43Molecular Weight (Monoisotopic): 314.1783AlogP: 5.15#Rotatable Bonds: 7
Polar Surface Area: 27.03Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.23CX LogP: 4.69CX LogD: 3.80
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.56Np Likeness Score: -1.05

References

1. Valant C, Maillet E, Bourguignon JJ, Bucher B, Utard V, Galzi JL, Hibert M..  (2009)  Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration.,  52  (19): [PMID:19746979] [10.1021/jm900671k]

Source